Genetic aspects of venous thrombosis : Third Symposium of the Wim Schellekens Foundation: Thrombophilia and ReproductionBERTINA, Rogier M.European journal of obstetrics, gynecology, and reproductive biology. 2001, Vol 95, Num 2, pp 189-192, issn 0301-2115Article

Hypercoagulable statesBERTINA, Rogier M.Seminars in hematology. 1997, Vol 34, Num 3, issn 0037-1963, 99 p.Serial Issue

Resistance to activated protein C as risk factor for thrombosis : Molecular mechanisms, laboratory investigation, and clinical managementDAHLBÄCK, B.Seminars in hematology. 1997, Vol 34, Num 3, pp 217-234, issn 0037-1963Article

Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasmaYUANA, Yuana; OSANTO, Susanne; BERTINA, Rogier M et al.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 3, pp 244-250, issn 0957-5235, 7 p.Article

C-reactive protein does not directly induce tissue factor in human monocytesPAFFEN, Elaine; VOS, Hans L; BERTINA, Rogier M et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 5, pp 975-981, issn 1079-5642, 7 p.Article

Pre-analytical and analytical issues in the analysis of blood microparticlesYUANA YUANA; BERTINA, Rogier M; OSANTO, Susanne et al.Thrombosis and haemostasis. 2011, Vol 105, Num 3, issn 0340-6245, 396-408 [13 p.]Article

Risk factors for venous thrombosis : Prevalence, risk, and interactionROSENDAAL, F. R.Seminars in hematology. 1997, Vol 34, Num 3, pp 171-187, issn 0037-1963Article

Genetic approach to thrombophiliaBERTINA, Rogier M.Thrombosis and haemostasis. 2001, Vol 86, Num 1, pp 92-103, issn 0340-6245Conference Paper

Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosisBOKAREWA, M. I; BLOMBÄCK, M.Seminars in hematology. 1997, Vol 34, Num 3, pp 235-243, issn 0037-1963Article

The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505DIRVEN, Richard J; VOS, Hans L; BERTINA, Rogier M et al.Thrombosis research. 2010, Vol 125, Num 5, pp 444-450, issn 0049-3848, 7 p.Article

Antithrombin and its inherited deficiency statesVAN BOVEN, H. H; LANE, D. A.Seminars in hematology. 1997, Vol 34, Num 3, pp 188-204, issn 0037-1963Article

Elevated factor VIII levels and the risk of thrombosisKAMPHUISEN, Pieter W; EIKENBOOM, Jeroen C. J; BERTINA, Rogier M et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 5, pp 731-738, issn 1079-5642Article

Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V leidenMEDINA, Pilar; NAVARRO, Silvia; ESTELLES, Amparo et al.Thrombosis and haemostasis. 2005, Vol 94, Num 2, pp 389-394, issn 0340-6245, 6 p.Article

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trialHØIBRAATEN, Else; MOWINCKEL, Marie-Christine; DE RONDE, Hans et al.British journal of haematology. 2001, Vol 115, Num 2, pp 415-420, issn 0007-1048Article

The R2-haplotype associated Asp2194Gly mutation in the light chain of human factor V results in lower expression levels of FV, but has no influence on the glycosylation of Asn2181VAN DER NEUT KOLFSCHOTEN, Marijn; DIRVEN, Richard J; L.VOS, Hans et al.Thrombosis and haemostasis. 2003, Vol 89, Num 3, pp 429-437, issn 0340-6245, 9 p.Article

Regulation of thrombin formation by activated protein C : Effect of the factor V leiden mutationTANS, G; NICOLAES, G. A. F; ROSING, J et al.Seminars in hematology. 1997, Vol 34, Num 3, pp 244-255, issn 0037-1963Article

Factor IX-R338L (Factor IX Padua) screening in a Dutch population of sibpairs with early onset venous thromboembolismKOENDERMAN, Jorine S; BERTINA, Rogier M; REITSMA, Pieter H et al.Thrombosis research. 2011, Vol 128, Num 6, issn 0049-3848, p. 603Article

Plasma coagulation factor levels in venous thrombosisYAËL NOSSENT, A; EIKENBOOM, Jeroen C. J; BERTINA, Rogier M et al.Seminars in hematology. 2007, Vol 44, Num 2, pp 77-84, issn 0037-1963, 8 p.Article

High factor VIII levels contribute to the thrombotic risk in families with factor V LeidenLENSEN, Ruud; BERTINA, Rogier M; VANDENBROUCKE, Jan P et al.British journal of haematology. 2001, Vol 114, Num 2, pp 380-386, issn 0007-1048Article

Familial thrombophilia : A complex genetic disorderKOELEMAN, B. P. C; REITSMA, P. H; BERTINA, R. M et al.Seminars in hematology. 1997, Vol 34, Num 3, pp 256-264, issn 0037-1963Article

Interleukin-6 induction of protein S is regulated through signal transducer and activator of transcription 3DE WOLF, Comelia J. F; CUPERS, Rosemiek M. J; BERTINA, Rogier M et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 9, pp 2168-2174, issn 1079-5642, 7 p.Article

The effect of plasma caeruloplasmin levels on the sensitivity for activated protein CDE VISSFR, Marieke C. H; SOUVERIJN, John H. M; ROSENDAAL, Frits R et al.British journal of haematology. 2002, Vol 118, Num 3, pp 843-846, issn 0007-1048Article

Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosisDE VISSER, Marieke C. H; POORT, Swibertus R; VOS, Hans L et al.Thrombosis and haemostasis. 2001, Vol 85, Num 6, pp 1011-1017, issn 0340-6245Article

Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidusNOSSENT, A. Yaël; ELLENBROEK, Johanne H; FRÖLICH, Marijke et al.Thrombosis research. 2010, Vol 125, Num 6, pp 554-556, issn 0049-3848, 3 p.Article

Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutationNAVARRO, Silvia; MEDINA, Pilar; MIRA, Yolanda et al.Haematologica (Roma). 2008, Vol 93, Num 6, pp 885-891, issn 0390-6078, 7 p.Article